Gábor O.
- Country
- Hungary
- Department
- Szent-Gyorgyi Albert Gyermekgyogyaszati Klinika es Gyermekegeszsegugyi Kozpont
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- (21196) A multicenter, prospective, open-label study to evaluate the pharmacokinetics and safety of gadoquatrane in pediatric participants (from birth to <18 years) undergoing contrast-enhanced magnetic resonance imaging (CE-MRI)
- Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors
Data & Insights
Has run more than one trial at 156 of 278 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating acute lymphoblastic leukemia (ALL) in pediatric patients, with particular focus on high-risk and relapsed cases. Their expertise extends to novel therapeutic approaches including immunotherapy treatments and specialized induction protocols.
- B-cell precursor ALL treatment
- CD22-positive leukemia management
- Risk-stratified therapy approaches
Pediatric Oncology
Their work encompasses treatment of rare pediatric cancers, including atypical teratoid/rhabdoid tumors (ATRT) and Ewing sarcoma. The investigator employs various therapeutic modalities including high-dose chemotherapy and radiation therapy protocols.
- ATRT treatment optimization
- Lymphoblastic lymphoma management
- Sarcoma therapy strategies
Diagnostic Imaging
The investigator has expertise in pediatric diagnostic imaging, particularly in contrast-enhanced magnetic resonance imaging procedures. Their work includes evaluation of contrast agents for optimal imaging outcomes in pediatric patients.
- MRI contrast enhancement protocols
- Pediatric imaging safety
- Diagnostic optimization techniques
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.